A Dose Escalation Study of Radio-labeled Antibody for the Treatment of Advanced Cancer
Clinical trial NCT02454010 · COMPLETED
Trial details
- NCT number
- NCT02454010
- Sponsor
- Fujifilm Pharmaceuticals U.S.A., Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-01
- Primary completion
- 2021-10-01
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.